Cargando…
The Potential of Antiviral Peptides as COVID-19 Therapeutics
Autores principales: | Mahendran, Arun Suria Karnan, Lim, Yin Sze, Fang, Chee-Mun, Loh, Hwei-San, Le, Cheng Foh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522797/ https://www.ncbi.nlm.nih.gov/pubmed/33041819 http://dx.doi.org/10.3389/fphar.2020.575444 |
Ejemplares similares
-
Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential
por: Rivera-Torres, José, et al.
Publicado: (2019) -
Editorial: Plant products for antiviral therapeutics
por: Mandal, Anirban, et al.
Publicado: (2022) -
The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease
por: Recio, Carlota, et al.
Publicado: (2017) -
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
por: Pfalzgraff, Anja, et al.
Publicado: (2018) -
An Improved Enzyme-Linked Focus Formation Assay Revealed Baloxavir Acid as a Potential Antiviral Therapeutic Against Hantavirus Infection
por: Ye, Chuantao, et al.
Publicado: (2019)